Brisbane, California--(Newsfile Corp. - October 25, 2022) - GT Biopharma, Inc. (NASDAQ: GTBP) (the "Company" or "GTB"), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary natural killer (NK) cell engager, TriKE^® platform, today announced that the Interim Chief...